Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongyi Li

Showing results (481-490 of 509) with videos related to

Pageof 51
Sort By:
Journal of Cancer|October 22, 2019
EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinomaYanghui Bi, Pengzhou Kong, Ling Zhang, et al.
Cancer Letters|August 21, 2020
Corrigendum to "FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer" [Canc. Lett. 397 (2017) 83-93]Xiaoling Hu, Yuanfang Zhai, Pengzhou Kong, et al.
Cancer Letters|April 4, 2017
FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancerXiaoling Hu, Yuanfang Zhai, Pengzhou Kong, et al.
Molecular Plant|June 3, 2022
Allele-aware chromosome-level genome assembly of Artemisia annua reveals the correlation between ADS expansion and artemisinin yieldBaosheng Liao, Xiaofeng Shen, Li Xiang, et al.
Technology in Cancer Research & Treatment|June 29, 2018
High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCCJie Yang, Pengzhou Kong, Jian Yang, et al.
Nature Communications|April 13, 2019
Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinomaTing Yan, Heyang Cui, Yong Zhou, et al.
Nature Communications|November 13, 2020
Author Correction: Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinomaTing Yan, Heyang Cui, Yong Zhou, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 25, 2025
Efficacy and Safety of Extending Dosing Interval of Stapokibart in Patients with Atopic DermatitisYan Zhao, Cheng Zhou, Xiaoyong Man, et al.
Cancer Cell|December 30, 2022
Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinomaZhihua Liu, Yahui Zhao, Pengzhou Kong, et al.
Oncotarget|January 20, 2018
The macro-evolutionary events in esophageal squamous cell carcinomaBin Yang, Ting Yan, Heyang Cui, et al.
Pageof 51

Showing results (481-490 of 509) with videos related to

Sort By:
Pageof 51
Journal of Cancer|October 22, 2019
EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinomaYanghui Bi, Pengzhou Kong, Ling Zhang, et al.
Cancer Letters|August 21, 2020
Corrigendum to "FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer" [Canc. Lett. 397 (2017) 83-93]Xiaoling Hu, Yuanfang Zhai, Pengzhou Kong, et al.
Cancer Letters|April 4, 2017
FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancerXiaoling Hu, Yuanfang Zhai, Pengzhou Kong, et al.
Molecular Plant|June 3, 2022
Allele-aware chromosome-level genome assembly of Artemisia annua reveals the correlation between ADS expansion and artemisinin yieldBaosheng Liao, Xiaofeng Shen, Li Xiang, et al.
Technology in Cancer Research & Treatment|June 29, 2018
High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCCJie Yang, Pengzhou Kong, Jian Yang, et al.
Nature Communications|April 13, 2019
Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinomaTing Yan, Heyang Cui, Yong Zhou, et al.
Nature Communications|November 13, 2020
Author Correction: Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinomaTing Yan, Heyang Cui, Yong Zhou, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 25, 2025
Efficacy and Safety of Extending Dosing Interval of Stapokibart in Patients with Atopic DermatitisYan Zhao, Cheng Zhou, Xiaoyong Man, et al.
Cancer Cell|December 30, 2022
Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinomaZhihua Liu, Yahui Zhao, Pengzhou Kong, et al.
Oncotarget|January 20, 2018
The macro-evolutionary events in esophageal squamous cell carcinomaBin Yang, Ting Yan, Heyang Cui, et al.
Pageof 51